Cargando…
Thyroid Cancer Risk Is Not Increased in Diabetic Patients
OBJECTIVE: This study evaluated thyroid cancer risk with regards to diabetes status and diabetes duration, and with the use of anti-diabetic drugs including sulfonylurea, metformin, insulin, acarbose, pioglitazone and rosiglitazone, by using a population-based reimbursement database in Taiwan. METHO...
Autor principal: | Tseng, Chin-Hsiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531389/ https://www.ncbi.nlm.nih.gov/pubmed/23300866 http://dx.doi.org/10.1371/journal.pone.0053096 |
Ejemplares similares
-
Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2016) -
Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014) -
Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014) -
Diabetes and Thyroid Cancer Risk: Literature Review
por: Shih, Shyang-Rong, et al.
Publicado: (2012) -
Diabetes but Not Insulin Increases the Risk of Lung Cancer: A Taiwanese Population-Based Study
por: Tseng, Chin-Hsiao
Publicado: (2014)